Lonza Signs Manufacturing Deal with Biopharma Firm

Lonza says it has entered into an agreement with biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ) for the production of Anthim, a therapeutic monoclonal antibody in late stage development for the treatment of anthrax infection. Lonza will...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers